MPM BioImpact Innovations Equities Fund, LTD. — Form D/A
MPM BioImpact Innovations Equities Fund, LTD. of GRAND CAYMAN, E9, a pooled investment fund, filed a Form D amendment with the SEC on 2025-06-27. $25.4M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-06-27
- Form: D/A
- Accession: 0000929638-25-002338
- Industry: Pooled Investment Fund
- Exemptions: 3C.7, 06b, 3C
- Amount sold: $25.4M
- Minimum investment: $1.0M
- Investors: 7
- Date of first sale: 2024-06-03
- Security types: equity, fund interests
- SEC file number: 021-517386
Issuer
- Name: MPM BioImpact Innovations Equities Fund, LTD.
- CIK: 0002028861
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2024
- Address: C/O OGIER GLOBAL (CAYMAN) LIMITED 89 Nexus Way, Camana Bay, GRAND CAYMAN, E9, KY1-9009
- Phone: 1 345-949-9876
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Brendan Furey | Director | Boston, MA |
| Alan Kelly | Director | Grand Cayman, E9 |
| Nicole Ramroop | Director | Grand Cayman, E9 |
| Nicole Ramroop | Related Person | Grand Cayman, E9 |
| Alan Kelly | Related Person | Grand Cayman, E9 |
| Brendan Furey | Related Person | Boston, MA |
Other filings by this issuer (2)
More